DNA ultra-sensitive quantification, a technology for studying HIV unintegrated linear DNA.

Area of Science:

• Virology
• Molecular Biology
• Immunology

Background:

• Unintegrated HIV DNA constitutes a significant portion of viral DNA in patients.
• Linear forms (unintegrated linear DNAs [ULDs]) are key substrates for viral integration and replication.
• Detecting ULDs is challenging due to limitations in current techniques' sensitivity and specificity.

Purpose of the Study:

• To develop a highly sensitive and specific method for quantifying unintegrated linear HIV DNA (ULDs).
• To investigate the stability and half-life of ULDs in different cellular states.
• To demonstrate the utility of the developed method for tracking pre-integrative HIV latency in patient samples.

Main Methods:

• Development of DNA ultra-sensitive quantification (DUSQ) technology.
• Combination of linker-mediated PCR and next-generation sequencing (NGS) with molecular barcodes.
• Analysis of ULDs in cells with varying activity levels and in patient-derived samples.

Main Results:

• The DUSQ method offers ultra-sensitive, specific, and high-throughput quantification of ULDs.
• ULDs exhibit a half-life of up to 11 days in resting CD4+ T cells.
• Successful quantification of ULDs in HIV-1 infected patient samples, validating DUSQ's in vivo application.

Conclusions:

• DUSQ is a powerful tool for quantifying rare DNA molecules like ULDs.
• The findings provide a novel approach to track pre-integrative HIV latency.
• DUSQ technology holds potential for broader applications in detecting other rare DNA targets.